Ausgabe 4/2004
Inhalt (35 Artikel)
The Icelandic founder mutation BRCA2 999del5: analysis of expression
Evgenia K Mikaelsdottir, Sigridur Valgeirsdottir, Jorunn E Eyfjord, Thorunn Rafnar
Manganese superoxide dismutase Ala-9Val polymorphism and risk of breast cancer in a population-based case–control study of African Americans and whites
Robert C Millikan, Jon Player, Allan René de Cotret, Patricia Moorman, Gary Pittman, Vani Vannappagari, Chiu-Kit J Tse, Temitope Keku
Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neuin a murine mammary carcinoma model
Yesim Eralp, Xiaoyan Wang, Jian-Ping Wang, Maureen F Maughan, John M Polo, Lawrence B Lachman
Conjugated docosahexaenoic acid suppresses KPL-1 human breast cancer cell growth in vitro and in vivo: potential mechanisms of action
Miki Tsujita-Kyutoku, Takashi Yuri, Naoyuki Danbara, Hideto Senzaki, Yasuhiko Kiyozuka, Norihisa Uehara, Hideho Takada, Takahiko Hada, Teruo Miyazawa, Yutaka Ogawa, Airo Tsubura
First description of feline inflammatory mammary carcinoma: clinicopathological and immunohistochemical characteristics of three cases
M Dolores Pérez-Alenza, Ángeles Jiménez, Ana I Nieto, Laura Peña
S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situof the breast
Ethan D Emberley, Salem Alowami, Linda Snell, Leigh C Murphy, Peter H Watson
Promoter methylation regulates cyclooxygenase expression in breast cancer
Xinrong Ma, Qingyuan Yang, Keith T Wilson, Namita Kundu, Stephen J Meltzer, Amy M Fulton
Dendritic cells loaded with killed breast cancer cells induce differentiation of tumor-specific cytotoxic T lymphocytes
Eve-Marie Neidhardt-Berard, Frederic Berard, Jacques Banchereau, A Karolina Palucka
Cytochrome P450 1A2 (CYP1A2) activity, mammographic density, and oxidative stress: a cross-sectional study
Chi-Chen Hong, Bing-Kou Tang, Venketeshwer Rao, Sanjiv Agarwal, Lisa Martin, David Tritchler, Martin Yaffe, Norman F Boyd
Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study
Chi-Chen Hong, Bing-Kou Tang, Geoffrey L Hammond, David Tritchler, Martin Yaffe, Norman F Boyd
Chemically induced DNA hypomethylation in breast carcinoma cells detected by the amplification of intermethylated sites
Bekim Sadikovic, Thomas R Haines, Darci T Butcher, David I Rodenhiser
The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer
Esther M John, John L Hopper, Jeanne C Beck, Julia A Knight, Susan L Neuhausen, Ruby T Senie, Argyrios Ziogas, Irene L Andrulis, Hoda Anton-Culver, Norman Boyd, Saundra S Buys, Mary B Daly, Frances P O'Malley, Regina M Santella, Melissa C Southey, Vickie L Venne, Deon J Venter, Dee W West, Alice S Whittemore, Daniela Seminara
Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity
Iman AF Azmy, Saba P Balasubramanian, Anthony G Wilson, Timothy J Stephenson, Angela Cox, Nicola J Brown, Malcolm WR Reed
No germline mutations in the histone acetyltransferase gene EP300 in BRCA1 and BRCA2 negative families with breast cancer and gastric, pancreatic, or colorectal cancer
Ian G Campbell, David Choong, Georgia Chenevix-Trench
Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients
Michael Retsky, Gianni Bonadonna, Romano Demicheli, Judah Folkman, William Hrushesky, Pinuccia Valagussa
Report on the 4th European Breast Cancer Conference, Hamburg, Germany, 16–20 March 2004
Elżbieta Senkus-Konefka, Jacek Jassem
Frequency of the ATM IVS10-6T→G variant in Australian multiple-case breast cancer families
Geoffrey J Lindeman, Melody Hiew, Jane E Visvader, Jennifer Leary, Michael Field, Clara L Gaff, RJ McKinlay Gardner, Kevin Trainor, Glenice Cheetham, Graeme Suthers, Judy Kirk
The DNMT3B C→T promoter polymorphism and risk of breast cancer in a British population: a case-control study
Karen G Montgomery, Mira CP Liu, Diana M Eccles, Ian G Campbell
Analysis of dendritic cells in tumor-free and tumor-containing sentinel lymph nodes from patients with breast cancer
Nancy J Poindexter, Aysegul Sahin, Kelly K Hunt, Elizabeth A Grimm
Common ataxia telangiectasia mutated haplotypes and risk of breast cancer: a nested case–control study
Rulla M Tamimi, Susan E Hankinson, Donna Spiegelman, Peter Kraft, Graham A Colditz, David J Hunter
Introducing Breast Cancer Research's updates on clinical trials
Martine Piccart, Eric Winer
Oestrogen receptor α gene haplotype and postmenopausal breast cancer risk: a case control study
Sara Wedrén, Lovisa Lovmar, Keith Humphreys, Cecilia Magnusson, Håkan Melhus, Ann-Christine Syvänen, Andreas Kindmark, Ulf Landegren, Maria Lagerström Fermér, Fredrik Stiger, Ingemar Persson, John Baron, Elisabete Weiderpass
Insulin-like growth factor (IGF)-I obliterates the pregnancy-associated protection against mammary carcinogenesis in rats: evidence that IGF-I enhances cancer progression through estrogen receptor-α activation via the mitogen-activated protein kinase pathway
Gudmundur Thordarson, Nicole Slusher, Harriet Leong, Dafne Ochoa, Lakshmanaswamy Rajkumar, Raphael Guzman, Satyabrata Nandi, Frank Talamantes
Expression of hypoxia-inducible factor-1α and cell cycle proteins in invasive breast cancer are estrogen receptor related
Reinhard Bos, Paul J van Diest, Petra van der Groep, Avi Shvarts, Astrid E Greijer, Elsken van der Wall
Cigarette smoking, cytochrome P4501A1 polymorphisms, and breast cancer among African-American and white women
Yu Li, Robert C Millikan, Douglas A Bell, Lisa Cui, Chiu-Kit J Tse, Beth Newman, Kathleen Conway
Drug concentrations in axillary lymph nodes after lymphatic chemotherapy on patients with breast cancer
Jianghao Chen, Ling Wang, Qing Yao, Rui Ling, Kaizong Li, Hui Wang
Does the act of surgery provoke activation of "latent" metastases in early breast cancer?
Michael Baum
Addition of granulocyte-colony stimulating factor (G-CSF) may further increase chemosensitive state in premenopausal node-positive breast cancer patients with induced angiogenesis after surgery
Kadri Altundag, Ozden Altundag, Mehmet Gunduz
Extreme growth factor signalling can promote oestrogen receptor-α loss: therapeutic implications in breast cancer
Julia MW Gee, Martin G Giles, Robert I Nicholson
Clinical trials update of the European Organization for Research and Treatment of Cancer Breast Cancer Group
Emiel JT Rutgers, Philip Meijnen, Hervé Bonnefoi